2021
DOI: 10.3389/fonc.2021.796839
|View full text |Cite
|
Sign up to set email alerts
|

Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α

Abstract: The transcription suppressor factor FBI-1 (the factor that binds to inducer of short transcripts-1) is an important regulator of hepatocellular carcinoma (HCC). In this work, the results showed that FBI-1 promoted the Warburg effect and enhances the resistance of hepatocellular carcinoma cells to molecular targeted agents. Knockdown of FBI-1 via its small-interfering RNA (siRNA) inhibited the ATP level, lactate productions, glucose uptake or lactate dehydrogenase (LDH) activation of HCC cells. Transfection of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 88 publications
0
7
0
Order By: Relevance
“…An increase of LDH-A expression is key in the metabolism of cancer cells and is considered a negative prognostic biomarker (32,33). LDH-A is upregulated in CD8+ T cells and fibroblast-like synoviocytes (FLSs) from rheumatoid arthritis patient and is considered a potential target to rewire the metabolism and reduces inflammatory response (34)(35)(36)(37).…”
Section: Sources and Metabolismmentioning
confidence: 99%
“…An increase of LDH-A expression is key in the metabolism of cancer cells and is considered a negative prognostic biomarker (32,33). LDH-A is upregulated in CD8+ T cells and fibroblast-like synoviocytes (FLSs) from rheumatoid arthritis patient and is considered a potential target to rewire the metabolism and reduces inflammatory response (34)(35)(36)(37).…”
Section: Sources and Metabolismmentioning
confidence: 99%
“…Researchers have focused on the immunotherapy of liver cancer. To enhance the sensitivity of the body to targeted drugs such as sorafenib, they have made various attempts and made some progresses, but there is still a gap from bench to clinical application ( 30 , 31 ).…”
Section: Discussionmentioning
confidence: 99%
“…This feature may suggest relevant genomic changes. The further study of these changes may have important implications for understanding tumor progression (17)(18)(19).…”
Section: Discussionmentioning
confidence: 99%